Amgen launches an AbbVie Humira biosimilar in the US

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/13/2026

1. ORCL
2. ADBE
3. RH
4. SPY
5. CPRT
6. ACVA
7. SEDG
8. SPCX
9. TLT
10. PMTS

Go back to Amgen launches an AbbVie Humira biosimilar in the US
AbbVie (NYSE: ABBV) Delayed: 257.12 +2.12 (0.83%)
Previous Close $255.00    52 Week High $68.12 
Open $253.92    52 Week Low $50.71 
Day High $259.61    P/E 55.77 
Day Low $253.92    EPS $4.61 
Volume 4,308,855       

Amgen Inc (NASDAQ: AMGN) Delayed: 377.35 -5.12 (1.34%)
Previous Close $382.47    52 Week High $176.85 
Open $386.14    52 Week Low $133.64 
Day High $386.99    P/E 56.83 
Day Low $377.22    EPS $6.64 
Volume 2,291,464